Moyana T - Search Results

1

Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansion.

Ye Z, Xu S, Moyana T, Yang J, Xiang J. Ye Z, et al. Among authors: moyana t. Cell Mol Immunol. 2008 Apr;5(2):147-52. doi: 10.1038/cmi.2008.18. Cell Mol Immunol. 2008. PMID: 18445345 Free PMC article.

2

Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.

He T, Tang C, Xu S, Moyana T, Xiang J. He T, et al. Among authors: moyana t. Cell Mol Immunol. 2007 Apr;4(2):105-11. Cell Mol Immunol. 2007. PMID: 17484804 Free article.

3

Alpha tumor necrosis factor contributes to CD8(+) T cell survival in the transition phase.

Shi M, Ye Z, Umeshappa KS, Moyana T, Xiang J. Shi M, et al. Among authors: moyana t. Biochem Biophys Res Commun. 2007 Aug 31;360(3):702-7. doi: 10.1016/j.bbrc.2007.06.126. Epub 2007 Jul 3. Biochem Biophys Res Commun. 2007. PMID: 17618911

4

Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.

Ye Z, Tang C, Xu S, Zhang B, Zhang X, Moyana T, Yang J, Xiang J. Ye Z, et al. Among authors: moyana t. Cell Mol Immunol. 2007 Aug;4(4):277-85. Cell Mol Immunol. 2007. PMID: 17764618 Free article.

5

Conversion of tolerogenic CD4-8- dendritic cells to immunogenic ones inducing efficient antitumor immunity.

Zhang X, Moyana T, Quereshi M, Xiang J. Zhang X, et al. Among authors: moyana t. Cancer Biother Radiopharm. 2006 Feb;21(1):74-80. doi: 10.1089/cbr.2006.21.74. Cancer Biother Radiopharm. 2006. PMID: 16480334

6

Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.

Xia D, Moyana T, Xiang J. Xia D, et al. Among authors: moyana t. Cell Res. 2006 Mar;16(3):241-59. doi: 10.1038/sj.cr.7310032. Cell Res. 2006. PMID: 16541123 Review.

7

Bidirectional membrane molecule transfer between dendritic and T cells.

He T, Tang C, Liu Y, Ye Z, Wu X, Wei Y, Moyana T, Xiang J. He T, et al. Among authors: moyana t. Biochem Biophys Res Commun. 2007 Jul 27;359(2):202-8. doi: 10.1016/j.bbrc.2007.05.099. Epub 2007 May 24. Biochem Biophys Res Commun. 2007. PMID: 17540342

8

Review: cancer immunotherapy by exosome-based vaccines.

Hao S, Moyana T, Xiang J. Hao S, et al. Among authors: moyana t. Cancer Biother Radiopharm. 2007 Oct;22(5):692-703. doi: 10.1089/cbr.2007.368-R. Cancer Biother Radiopharm. 2007. PMID: 17979572 Review.

9

Autologous human B-cell immune response to pulmonary adenocarcinomatous polymorphic epithelial mucin.

Xiang J, Moyana T, Maksymiuk A. Xiang J, et al. Among authors: moyana t. J Clin Immunol. 1995 Mar;15(2):74-9. doi: 10.1007/BF01541735. J Clin Immunol. 1995. PMID: 7559911

10

A genetically engineered single-chain FV/TNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor.

Yang J, Moyana T, Xiang J. Yang J, et al. Among authors: moyana t. Mol Immunol. 1995 Aug;32(12):873-81. doi: 10.1016/0161-5890(95)00051-f. Mol Immunol. 1995. PMID: 7565814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters